Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2015-02-27 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
第八届董事会第十六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from the board of directors of a company regarding resolutions passed at a board meeting. It details changes in the board structure, including the election of a new vice chairman, adjustments to board committees, organizational restructuring, and changes in senior management positions. There are no financial statements, earnings data, or audit information presented. The content focuses on management and board-level decisions and appointments. Therefore, this document fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication, so it is not RPA. It is not a regulatory filing or certification. Hence, the classification is MANG with high confidence.
2015-02-27 Chinese
2015年第一次临时股东大会法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, attendance, voting, and results of a 2015 first extraordinary general meeting (临时股东大会) of a company. It details the meeting date, voting methods, attendance, and resolutions passed. It does not contain financial statements or financial performance data. It is not an announcement of voting results only, but a legal opinion on the meeting's legality and validity. The document is focused on the meeting and its resolutions, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The length is under 5,000 characters, but the content is substantive about voting results and legal opinion on the meeting, not just a brief announcement or report publication. Therefore, the best fit is DVA.
2015-02-27 Chinese
关于召开2015年第一次临时股东大会的再次通知
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed notice about the convening of the 2015 first extraordinary general meeting of shareholders (临时股东大会) for the company 中源协和细胞基因工程股份有限公司. It includes information about the meeting date, voting methods (including online voting), agenda items to be discussed and voted on, instructions for shareholders, and proxy authorization forms. There is no financial data or results reported, nor is it a transcript or presentation. It is a formal announcement and notification related to a shareholders meeting, specifically a notice to convene the meeting and provide details for participation and voting. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA) or Proxy Solicitation & Information Statement (PSI). However, since this document is a notice of the meeting and voting procedures rather than the solicitation materials or proxy statement itself, and it is not reporting voting results, it is best classified as a Proxy Solicitation & Information Statement (PSI) because it provides information to shareholders to prepare for voting and includes proxy forms. The document length is 3136 characters, which is consistent with a detailed meeting notice and proxy information rather than a full report or announcement of results.
2015-02-16 Chinese
第八届董事会第十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at a board meeting, specifically about changes in senior management positions (appointment and removal of vice general managers) and approval of their remuneration. It includes details about the meeting procedure, voting results, and brief biographies of the appointed individuals. There are no financial statements or detailed financial performance data. The content focuses on management changes and governance matters. Therefore, the document fits the category of Board/Management Information (MANG). The document length is short and it is not a report or a notice of a report publication, so it is not RPA or RNS. Hence, the classification is MANG with high confidence.
2015-02-12 Chinese
独立董事关于高级管理人员薪酬事项的独立意见
Remuneration Information Classification · 95% confidence The document is a statement from independent directors regarding the remuneration of senior management, expressing their independent opinion on the salary matters approved by the board. It references governance codes and company bylaws, and is focused on remuneration approval rather than detailed compensation disclosures or full remuneration reports. This fits the definition of a Remuneration Information filing, which details compensation for top executives and directors. The document is short and specific to remuneration approval, not a full report or announcement of a meeting or vote result.
2015-02-12 Chinese
独立董事关于聘任高级管理人员的独立意见
Board/Management Information Classification · 100% confidence The document is an independent opinion from independent directors regarding the appointment and removal of senior management personnel. It discusses board decisions about management changes and confirms compliance with relevant laws and company articles. There is no financial data, no report publication, no voting results, and no other regulatory filings. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2015-02-12 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.